Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
Tom Stephan from Stifel Nicolaus issued a price target of $16.00 for CLPT on 2026-06-09 13:09:00.The adjusted price target was set to $16.00.At the time of the announcement,
June 9, 2026 CLPT -3.74%
from Northland Securities issued a price target of $111.00 for GHM on 2026-06-09 12:56:23.The adjusted price target was set to $111.00.At the time of the announcement, GHM...
June 9, 2026 GHM -0.65%
from Oppenheimer issued a price target of $110.00 for GHM on 2026-06-09 11:39:20.The adjusted price target was set to $110.00.At the time of the announcement, GHM was...
June 9, 2026 GHM -0.65%
Matt Koranda from Roth Capital issued a price target of $5.50 for TLYS on 2026-06-08 13:41:59.The adjusted price target was set to $5.50.At the time of the announcement,
June 8, 2026 TLYS -0.95%
from Roth Capital issued a price target of $20.00 for VBNK on 2026-06-08 13:33:59.The adjusted price target was set to $20.00.At the time of the announcement, VBNK...
June 8, 2026 VBNK -1.32%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| VCIG VCI Global Limited | 5.68
26.67% | ||||||||||||||||||
| PMEC Primech Holdings Ltd. Ord | 0.70
20.65% | ||||||||||||||||||
| QRHC Quest Resource Holding Co | 1.41
9.77% | ||||||||||||||||||
| TSLQ Tradr 2X Short TSLA Daily | 20.11
9.17% | ||||||||||||||||||
| RVPH Reviva Pharmaceuticals Ho | 0.73
9.13% | ||||||||||||||||||
| TELA TELA Bio, Inc. | 0.92
8.24% | ||||||||||||||||||
| SCLXW SCLXW | 0.16
8.22% | ||||||||||||||||||
| CTSO Cytosorbents Corporation | 0.45
8.11% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP -8.45%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE -11.06%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK -0.91%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 1.20%